Thanks Haywain, reassuringly knowledgeable as ever. Re 12 months for patient 1 in February, does that marvellous milestone bring a requirement for greater clarity or just a very obvious opportunity? Ps wishing happy 2026 to all.
Time to leave this board to the pondlife. It is clear that the shorters / traders /parasites have done what they intended to Hemo's sp so that they and their owners can get in as cheaply as they wished. There are 2 types of parasite - those that kill the host and those that just chronically debilitate the host: how tragic and ironic if these parasites have done for Hemo and the golden goose cannot recover after all.
RE: It's obvious the science works now3 Dec 2025 17:21
Once again thanks to the green-boxed parasite/s who nettled Haywain into providing another excellent summary of where this trial really stands, appreciated. (Thanks to Haywain too :)
There’s no “misleading” here at all. The reality is simple:Hemogenyx isn’t going to be valued in pounds by a few UK day-traders – it will be valued in dollars by US institutions once efficacy is published.
That is the entire point. The UK market is irrelevant to the end-game.Right now the only missing piece between where we sit today and the valuation HH has been pointing toward is the formal publication of efficacy in black and white. When that drops, sentiment games, short baiting and anonymous posters won’t matter. Clinical data rewrites the valuation instantly because US pharma, US funds and US strategics price off outcomes - not off the opinions of low life share manipulators .
Wonder how many parasite posts have been reported and yet they are still here spewing their bile as if they are protected. The FCA should be looking at the LSE moderators as well.
RE: Soon we will be looking back @ this crazy low shareprice25 Nov 2025 08:20
Sadly Aldebaran is not just an attention seeker - he is a morally bankrupt vile manipulator who is trying to scare investors into selling shares so he can buy them more cheaply when he's ready.